References and Notes
Reviews for the preparation and use of cyclopropanes:
<A NAME="RU13506ST-1A">1a</A>
Wong HNC.
Hon M.-Y.
Tse C.-W.
Yip Y.-C.
Tanko J.
Hudlicky T.
Chem. Rev.
1989,
89:
165
<A NAME="RU13506ST-1B">1b</A>
Davies HML.
Comprehensive Organic Synthesis
Vol. 4:
Trost BM.
Fleming I.
Pergamon;
Oxford:
1991.
Chap. 4.8.
p.1031-1067
<A NAME="RU13506ST-1C">1c</A>
Ye T.
McKervey MA.
Chem. Rev.
1994,
94:
1091
<A NAME="RU13506ST-1D">1d</A>
Doyle MP.
Protopopova MN.
Tetrahedron
1998,
54:
7919
<A NAME="RU13506ST-1E">1e</A>
Doyle MP.
Catalytic Asymmetric Synthesis
2nd ed.:
Ojima I.
YHC Publishers;
New York:
2000.
Chap. 5.
p.191-228 ; and references cited therein
<A NAME="RU13506ST-2A">2a</A>
Kondo K.
Takahatake Y.
Sugimoto K.
Tunemoto D.
Tetrahedron Lett.
1978,
907
<A NAME="RU13506ST-2B">2b</A>
Tanimori S.
Kainuki T.
Nakayama M.
Biosci., Biotechnol., Biochem.
1992,
56:
1807
<A NAME="RU13506ST-3A">3a</A>
Nemoto H.
Wu XM.
Kurobe H.
Ihara M.
Fukumoto K.
Kametani T.
Tetrahedron Lett.
1983,
24:
4257
<A NAME="RU13506ST-3B">3b</A>
Wilson SR.
Haque MS.
Venkatesan AM.
Zucker PA.
Tetrahedron Lett.
1984,
25:
3151
<A NAME="RU13506ST-3C">3c</A>
Nemoto H.
Wu XM.
Kurobei H.
Minemura K.
Ihara M.
Fukumoto K.
Kametani T.
J. Chem. Soc., Perkin Trans. 1
1985,
1185
<A NAME="RU13506ST-3D">3d</A>
Nemoto H.
Kimura T.
Kurobe H.
Fukumoto K.
Kametani T.
J. Chem. Soc., Perkin Trans. 1
1986,
1777
<A NAME="RU13506ST-3E">3e</A>
Taber DF.
Amedio JC.
Raman K.
J. Org. Chem.
1988,
53:
2984
<A NAME="RU13506ST-3F">3f</A>
Wilson SR.
Venkatesan AM.
Augelli-Szafran CE.
Yasmin A.
Tetrahedron Lett.
1991,
32:
2339
<A NAME="RU13506ST-3G">3g</A>
Moriarty RM.
Kim J.
Guo L.
Tetrahedron Lett.
1993,
34:
4129
<A NAME="RU13506ST-3H">3h</A>
Tanimori S.
Tsubota M.
He M.
Nakayama M.
Synth. Commun.
1997,
27:
2371
<A NAME="RU13506ST-4">4</A>
Taber DF.
Saleh SA.
Korsmeyer RW.
J. Org. Chem.
1980,
45:
4699
<A NAME="RU13506ST-5A">5a</A>
Dauben WG.
Hendricks RT.
Luzzio MJ.
Ng HP.
Tetrahedron Lett.
1990,
31:
6969
<A NAME="RU13506ST-5B">5b</A>
Pique C.
Fahndrich B.
Pfaltz A.
Synlett
1995,
491 ; Special Issue
<A NAME="RU13506ST-5C">5c</A>
Park S.-W.
Son J.-H.
Kim S.-G.
Ahn KH.
Tetrahedron: Asymmetry
1999,
10:
1903
<A NAME="RU13506ST-5D">5d</A>
Kim SG.
Cho CW.
Ahn KH.
Tetrahedron
1999,
55:
10079
<A NAME="RU13506ST-5E">5e</A>
Barberis M.
Estevan F.
Lahuerta P.
Perez-Prieto J.
Sanau M.
Inorg. Chem.
2001,
40:
4226
<A NAME="RU13506ST-5F">5f</A>
Barberis M.
Perez-Prieto J.
Stiriba S.-E.
Lahuerta P.
Org. Lett.
2001,
3:
3317
<A NAME="RU13506ST-5G">5g</A>
Saha B.
Uchida T.
Katsuki T.
Chem. Lett.
2002,
8:
846
<A NAME="RU13506ST-5H">5h</A>
Barberis M.
Perez-Prieto J.
Herbst K.
Lahuerta P.
Organometallics
2002,
21:
1667
<A NAME="RU13506ST-5I">5i</A>
Saha B.
Uchida T.
Katsuki T.
Tetrahedron: Asymmetry
2003,
14:
823
<A NAME="RU13506ST-5J">5j</A>
Wong A.
Welch CJ.
Kuethe JT.
Vazquez E.
Shaimi M.
Henderson D.
Davies IW.
Hughes DL.
Org. Biomol. Chem.
2004,
2:
168
<A NAME="RU13506ST-5K">5k</A>
Estevan F.
Lahuerta P.
Lloret J.
Perez-Prieto J.
Werner H.
Organometallics
2004,
23:
1369
<A NAME="RU13506ST-5L">5l</A>
Estevan F.
Lahuerta P.
Lloret J.
Penno D.
Sanau M.
Ubeda MA.
J. Organomet. Chem.
2005,
690:
4424
<A NAME="RU13506ST-5M">5m</A>
Uchida T.
Katsuki T.
Synthesis
2006,
1715
<A NAME="RU13506ST-6A">6a</A>
For the attempted catalytic asymmetric IMCP of 2-diazo-3-oxo-6-heptenoic acid esters,
see ref. 5a.
<A NAME="RU13506ST-6B">6b</A>
He M.
Tanimori S.
Ohira S.
Nakayama M.
Tetrahedron
1997,
53:
13307
<A NAME="RU13506ST-6C">6c</A>
Mühler P.
Boléa C.
Helv. Chim. Acta
2001,
84:
1093
<A NAME="RU13506ST-7A">7a</A>
Honma M.
Sawada T.
Fujisawa Y.
Utsugi M.
Watanabe H.
Umino A.
Matsumura T.
Hagihara T.
Takano M.
Nakada M.
J. Am. Chem. Soc.
2003,
125:
2860
<A NAME="RU13506ST-7B">7b</A>
Honma M.
Nakada M.
Tetrahedron Lett.
2003,
44:
9007
<A NAME="RU13506ST-7C">7c</A>
Sawada T.
Nakada M.
Adv. Synth. Catal.
2005,
347:
1527
<A NAME="RU13506ST-7D">7d</A>
Takeda H.
Nakada M.
Tetrahedron: Asymmetry
2006,
17:
2896
Total synthesis of natural products utilizing the catalytic asymmetric IMCP of α-diazo-β-keto
sulfones:
<A NAME="RU13506ST-7E">7e</A> (-)-Allocyathin B2:
Takano M.
Umino A.
Nakada M.
Org. Lett.
2004,
6:
<A NAME="RU13506ST-7F">7f</A> (-)-Malyngolide:
Miyamoto H.
Iwamoto M.
Nakada M.
Heterocycles
2005,
66:
61
<A NAME="RU13506ST-7G">7g</A> (-)-Methyl jasmonate:
Takeda H.
Watanabe H.
Nakada M.
Tetrahedron
2006,
62:
8054
<A NAME="RU13506ST-8">8</A>
General Procedure.
A toluene azeotroped [CuOTf]2·toluene (7.7 mg, 0.0148 mmol, 10 mol% as CuOTf) was placed in a dried flask under
Ar atmosphere. To this flask was added toluene (4 mL) and then a solution of toluene
azeotroped ligand 3c (13.1 mg, 0.0445 mmol, 15 mol%) in toluene (2 × 0.5 mL) via a cannula. The mixture
was stirred at r.t. for 0.5 h and then a solution of toluene azeotroped 2,6-di-tert-butyl-4-methyl-phenyl 2-diazo-3-oxo-6-heptenoate (10, 110.0 mg, 0.297 mmol) in toluene (2 × 0.5 mL) was added to the light blue solution
via a cannula. The reaction mixture was stirred at 50 °C for 45.5 h, quenched with
a mixture of sat. aq NH4Cl solution (1 mL) and NH4OH aq solution (3 mL), and extracted with Et2O (2 × 2 mL). The combined organic layer was washed with brine (2 mL), dried over
Na2SO4, and eva-porated. The residue was purified by flash chromatography (hexane-EtOAc,
10:1) to afford 2-oxobicyclo[3.1.0]hexane-1-carboxylic acid 2,6-di-tert-butyl-4-methylphenyl ester (14, 57.0 mg, 56%, 78% ee) as a white solid. The absolute configuration was determined
as described in the text. The ee was determined as described in ref. 9: [α]D
28 -23.0 (c 0.45, CHCl3, 78% ee). IR (KBr): νmax = 2984, 1761, 1727, 1324, 1264, 1189, 1139, 1076, 1033, 781, 714 cm-1. 1H NMR (400 MHz, CDCl3): δ = 7.09 (s, 1 H), 7.08 (8) (s, 1 H), 2.76 (ddd, J = 8.1, 5.4, 5.4 Hz, 1 H), 2.38-2.06 (m, 9 H including δ = 2.31, s, 3 H), 1.37 (s,
9 H), 1.30 (s, 9 H). 13C NMR (100 MHz, CDCl3): δ = 205.3, 169.2, 145.7, 142.1, 141.7, 134.5, 126.9, 38.2, 35.3, 35.1, 34.2, 34.0,
31.4 (4), 31.4, 23.3, 21.5, 20.8. HRMS-FAB: m/z calcd for C22H30O3 + H: 343.2273; found: 343.2285.
<A NAME="RU13506ST-9">9</A>
Compound 12: DAICEL CHIRALCEL OD-H ∅ 0.46 cm × 25 cm; hexane-2-PrOH = 9:1; flow rate = 0.5 mL/min);
t
R = 15.0 min for ent-12, 18.2 min for 12.
Compound 13: DAICEL CHIRALPAK AS-H ∅ 0.46 cm × 25 cm; hexane-2-PrOH = 4:1; flow rate = 0.5 mL/min);
t
R = 25.8 min for ent-13, 28.8 min for 13.
Compound 14 was converted into its oxime, which was benzoylated and subjected to HPLC analysis:
DAICEL CHIRALCEL OD-H ∅ 0.46 cm × 25 cm; hexane-2-PrOH = 14:1; flow rate = 0.2 mL/min);
t
R: 25.8 min for ent-14, 28.8 min for 14.